Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 26:2018:bcr2017223507.
doi: 10.1136/bcr-2017-223507.

Clarithromycin as a steroid sparing agent for the management of infantile bullous pemphigoid

Simon Tso  1 , Gabriela Petrof  2 , Simon Unter  2 , Frances Humphreys  2
Affiliations
Review

Clarithromycin as a steroid sparing agent for the management of infantile bullous pemphigoid

Simon Tso et al. BMJ Case Rep. .
No abstract available

Keywords: dermatology; paediatrics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The patient’s right foot with widespread intact bullae with an erythematous base.
Figure 2
Figure 2
The patient’s lower limbs 2 months after completion of all treatments with complete resolution of the bullous eruption.
See this image and copyright information in PMC

References

    1. Schwieger-Briel A, Moellmann C, Mattulat B, et al. . Bullous pemphigoid in infants: characteristics, diagnosis and treatment. Orphanet J Rare Dis 2014;9:185 doi:10.1186/s13023-014-0185-6 - DOI - PMC - PubMed
    1. Ferreira BR, Vaz AS, Ramos L, et al. . Bullous pemphigoid of infancy - report and review of infantile and pediatric bullous pemphigoid. Dermatol Online J 2017;23. - PubMed
    1. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010;23:590–615. doi:10.1128/CMR.00078-09 - DOI - PMC - PubMed